Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism

Area of Science:

• Endocrinology
• Nephrology
• Nutritional Biochemistry

Background:

• Primary hyperparathyroidism (PHPT) is a common endocrine disorder characterized by excessive parathyroid hormone (PTH) secretion.
• Vitamin D metabolism and renal function are closely linked and can be altered in PHPT.
• Understanding the determinants of active vitamin D (1,25-dihydroxyvitamin D3) in PHPT is crucial for managing calcium-phosphate balance.

Purpose of the Study:

• To investigate the relationships between serum levels of vitamin D metabolites (25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3), parathyroid hormone (PTH), calcium, phosphate, and renal function (creatinine clearance) in patients with PHPT.

Main Methods:

• Cross-sectional study involving 34 patients with primary hyperparathyroidism.
• Measurement of serum 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3, C-terminal immunoreactive PTH, calcium, and phosphate.
• Assessment of endogenous creatinine clearance (Clcr) to evaluate renal function.

Main Results:

• Elevated serum iPTH was observed in 82% of patients and correlated positively with serum calcium and inversely with Clcr.
• Reduced serum 25(OH)D3 was noted in 28% of patients, linked to multivitamin supplementation.
• Serum 1,25(OH)2D3 showed complex correlations with 25(OH)D3, Clcr, calcium, phosphate, and iPTH. Multiple regression indicated that 25(OH)D3 and Clcr were the primary determinants of 1,25(OH)2D3 levels.

Conclusions:

• Serum 25-hydroxyvitamin D3 levels and renal function are the principal determinants of serum 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism.
• These findings underscore the importance of assessing vitamin D status and kidney function in the comprehensive management of PHPT.